Biotech

All Articles

Biogen, UCB document phase 3 lupus gain after neglecting earlier trial

.Biogen and UCB's gamble on developing in to period 3 astride a broken research study tries to have ...

Aptadir really hopes brand-new RNA preventions can easily turn around complicated cancers cells

.Italian biotech Aptadir Therapeutics has introduced with the guarantee that its pipe of preclinical...

Wave surfs DMD effectiveness to regulatory authorities' doors, delivering stock up

.Surge Lifestyle Sciences has satisfied its own objective in a Duchenne muscle dystrophy (DMD) resea...

Sanofi tweezes brand-new CSO coming from in-stealth biotech

.After a couple of years in biotech, Mike Quigley, Ph.D., is going back to the pharma crease, using ...

Achilles drips tissue treatment system, braces for cutbacks after missing out on 'office stability' targets

.Achilles Therapeutics has actually wrecked its own approach. The English biotech is knocking off on...

Aligos trumpets period 2 MASH win, reducing liver fat around 46%

.Aligos Therapeutics is actually declaring a midstage win in metabolic-dysfunction linked steatohepa...

Basilea credit ratings $268M BARDA financing for antifungals, antibiotics

.Basilea Pharmaceutica's job creating brand new antifungals has acquired a substantial improvement c...

Capricor markets Europe civil liberties to late-stage DMD treatment for $35M

.Possessing currently gathered up the U.S. civil liberties to Capricor Therapies' late-stage Duchenn...

FDA scraps adcomm for Applied's unusual ailment medication

.After pushing back the selection date for Applied Therapies' metabolic condition medicine govoresta...

Novo inks $600M NanoVation offer to research genetic drugs ex-liver

.Novo Nordisk is proceeding its own push right into genetic medicines, accepting to pay NanoVation T...